• David McClure PhD

  • Epidemiologist - Senior


    • Center for Clinical Epidemiology & Population Health
    • 1000 North Oak Ave. ML2 Marshfield, WI 54449

Education


1980 to 1984:
BS, Physics, Arizona State University, Tempe Arizona
1984 to 1986:
MS, Materials Science, Arizona State University, Tempe Arizona
1995 to 1997:
MS, Medical Physics, University of Colorado Health Sciences Center, Denver Colorado
1998 to 2005:
PhD, Analytical Health Sciences (Epidemiology/Biostatistics), University of Colorado Health Sciences Center, Denver Colorado

Work Experience


2000 to 2002:
Biostatistician and Outcomes Analyst, National Jewish Medical and Research Center, Denver Colorado
2002 to 2012:
Senior Biostatistician/Epidemiologist, Kaiser Permanente Colorado, Denver Colorado
2012 to 2014:
Epidemiologist, Marshfield Clinic Research Foundation, Marshfield Wisconsin
2014 to 2015:
Project Scientist/Advisor, CVS Health, Northbrook Illinois
2014 to Present:
Adjunct Assistant Professor, Medical College of Wisconsin, Milwaukee Wisconsin
2016 to Present:
Senior Epidemiologist, Marshfield Clinic Research Institute, Marshfield Wisconsin

Statement


Dr. McClure is a senior epidemiologist specializing in pharmacoepidemiology with emphasis in vaccine safety and effectiveness. He has collaborated with CCEPH staff for many years via the CDC sponsored Vaccine Safety Datalink prior to his most recent CCEPH appointment in 2016. He also has interests in leading or supporting studies of infectious disease, rural health, or new epidemiologic methods.

Research Interests


Vaccine safety and effectiveness, Pharmacoepidemiology, Epidemiologic methods,
Infectious disease epidemiology, Rural health epidemiology

Select Publications


  • Glanz JM, Newcomer SR, Daley MF, McClure DL, Baxter RP, Jackson ML,...DeStefano F. (2015 November 27). Cumulative and episodic vaccine aluminum exposure in a population-based cohort of young children. VACCINE. 33(48):6736-44..
    PubMed ID: 26518400
  • Simpson MD, Kieke BA, Sundaram ME, McClure DL, Meece JK, Sifakis F,...Belongia EA. (2016 April). Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6-59 Months Old During Four Seasons. Open Forum Infect Dis.. 3(2):ofw081.
    PubMed ID: 27419158
  • Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM,...Belongia EA. (2017 October 13). Risk of venous thromboembolism following influenza vaccination in adults aged 50years and older in the Vaccine Safety Datalink. VACCINE. 35(43):5872-5877.
    PubMed ID: 28888342